Centrus Energy

Centrus Energy staged a single-session rally during regular trading, surging 5.15% to $164.45 as of 10:30 ET, driven by a cluster of catalysts: the company's recent $900 million DOE contract to deploy HALEU capacity by 2032, its intention to transition the HALEU production cascade to commercial operation, and its inclusion in the S&P SmallCap 600 index. Needham previously highlighted the stock as 'at a discount' amid a structural uranium enrichment deficit. Despite the strong move, shares remain 64.58% below the 52-week high of $464.25 and down 39.65% year-to-date, though they have reclaimed the 20-day moving average of $164.4, signaling an attempt to repair the medium-term trend. However, the post-market quote slipped to $156.0, suggesting near-term profit-taking.

Centrus Energy staged a significant intraday rally today, climbing from a regular-session open of $143.95 to an intraday high of $157.96 before settling at $156.38, up approximately 6.3% from the prior close of $147.07, though it retreated to $146.46 in after-hours trading. The surge was primarily driven by a recently secured $900 million DOE contract to deploy HALEU capacity by 2032 and news of its impending addition to the S&P SmallCap 600 Index, alongside heightened market expectations regarding a structural uranium enrichment deficit. Earnings data showed Q1 net profit of $10 million, down 63.24% YoY, with EPS of $0.45 falling 71.88% YoY, while revenue of $76.7 million edged up 4.92% YoY, a mixed fundamental picture that did not dampen the day's rally. However, the stock remains 66.32% below its 52-week high of $464.25, trading below both the MA20 ($167.13) and MA60 ($181.34), with a YTD decline of 42.61%, indicating the rebound is still within a low range.

Centrus Energy traded sharply lower during regular hours, last at $148.51 as of 09:44 ET, down 5.1% from the prior close of $156.54. The stock opened weak and continued to slide, hitting an intraday low of $148.51 — a new 52-week low, now 68% below its 52-week high of $464.25. The selloff was driven by disappointing Q1 2026 earnings: net profit plunged 63.24% YoY to just $10 million, with operating income turning negative at -$0.2 million, while revenue of $76.7 million was only up 4.92% YoY and well below the prior quarter's $146.2 million. EPS fell 71.88% to $0.45. Recent analyst actions added pressure, with J.P. Morgan assigning a Hold rating and a price target of $269.69, while Needham noted the stock is 'at a discount' amid a looming structural uranium enrichment deficit. However, the company secured a $900 million DOE contract for HALEU capacity and was added to the S&P SmallCap 600 index, which could support long-term demand.

Centrus Energy (LEU) plunged about 5.3% in regular trading, pressured by a 'Hold' rating from J.P. Morgan, while Needham's comment that the stock is 'at a discount' failed to stem the decline. The stock fell sharply from its pre-market high of $162.95 to an intraday low of $151.20, closing at $151.12. Despite a $900 million DOE contract for HALEU deployment, Q1 net profit dropped 63% YoY to $10 million, with operating income turning negative. The stock is 67% below its 52-week high of $464.25, trading below both its 20-day ($168.5) and 60-day ($182.7) moving averages, with a YTD loss of 44.5%. However, after-hours trading rebounded to $159.94, suggesting some late-day buying interest.

Centrus Energy shares experienced a volatile session, initially surging to an intraday high of $165.30 before retreating to close at $159.72, up 2.4% from the prior close of $156.05. The catalyst was the announcement of a $900 million DOE contract to deploy HALEU capacity by 2032 and news of its inclusion in the S&P SmallCap 600 Index. However, J.P. Morgan initiated coverage with a 'Hold' rating, while Needham maintained a 'Buy' but cut its price target from $370 to $269.69, still implying 63% upside. The stock remains 65.6% below its 52-week high of $464.25 and has declined 41.4% year-to-date, trading below both its 20-day ($169.76) and 60-day ($183.59) moving averages. Post-market saw the stock edge back up to $159.5.